BRE-4-MED participants with baseline information | |
---|---|
Female sex, n (%) | 30 (96.8) |
Age, mean (std), years | 57.1 (± 13.5) |
Time since diagnosis of MBC, median (IQR), months | 21.0 (7–45) |
Care given by family member*, n (%) | 6 (21.4) |
Returned questionnaires of family members*, n (%) | 15 (50.0) |
Number of metastasis location, n (%) | |
1 | 9 (29.0) |
2 | 10 (32.3) |
3 | 5 (16.1) |
4 | 5 (16.1) |
5 | 1 (3.2) |
6 | 1 (3.2) |
Kind of administered medication, n (%) | |
No information on medication specified | 1 (3.2) |
Oral only | 2 (6.5) |
Oral + subcutaneous | 1 (3.2) |
IV only | 14 (45.2) |
IV + oral | 11 (35.5) |
IV + oral and subcutaneous | 2 (6.5) |